middle.news
How Will Anatara’s Anti-Obesity Trials and $1.2M Placement Shape Its Future?
8:46am on Thursday 23rd of October, 2025 AEDT
•
Healthcare
Read Story
How Will Anatara’s Anti-Obesity Trials and $1.2M Placement Shape Its Future?
8:46am on Thursday 23rd of October, 2025 AEDT
Key Points
Anti-Obesity Project pre-clinical studies progressing on schedule
GaRP gastrointestinal product data being prepared for publication
Board refresh with Dirk van Dissel appointed Non-Executive Director
Received $0.969 million Australian Government R&D tax incentive refund
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Anatara Lifesciences (ASX:ANR)
OPEN ARTICLE